Low-Dose Chemotherapy May Help Lupus Nephritis News Update February 22, 2021 In a recent study published in Arthritis & Rheumatology, LRA-funded researcher Dr. Xian Zhang found that a...
NIH Work Co-Supported by LRA May Simplify Lupus Nephritis Monitoring News Update June 20, 2019 As reported by the National Institutes of Health (NIH), research published by the NIH Accelerating Medicines Partnership (AMP)...
Aurinia Moves Voclosporin Closer to FDA Approval for Lupus Nephritis News Update March 16, 2020 The Lupus Research Alliance is pleased to share an announcement from Aurinia Pharmaceuticals that moves its potential...
LRA Pleased to Share News of Lupus Nephritis Clinical Trial Launch News Update October 1, 2019 The Lupus Research Alliance is pleased to share news about the launch of EQUALISE, a Phase 1b...
New Approach to Treating Lupus Nephritis News Update February 6, 2019 Scientists partly funded by the Lupus Research Alliance have found a potential new way to protect the...
Iguratimod as an Alternative Therapy for Resistant Lupus Nephritis News Update April 1, 2020 An investigational treatment, iguratimod showed positive results in an early clinical study of people with lupus nephritis...
Lupus Research Alliance Applauds Phase III Trial Results for Potential Lupus Nephritis Treatment News Update December 4, 2019 The Lupus Research Alliance congratulates Aurinia Pharmaceuticals on achieving the first positive Phase III trial results for...
LRA Uncovering What Causes Lupus Nephritis to Improve Treatment News Update January 16, 2020 The Lupus Research Alliance has invested millions in research to get us to the point we’re at...
New Phase 3 Study Shows Positive Results for Benlysta® in Lupus Nephritis Press Release December 17, 2019 The Lupus Research Alliance is thrilled to share exciting news from GSK that Benlysta (belimumab) demonstrated positive...
Aurinia Announces Positive Long-Term Results on Lupykinis™ for Lupus Nephritis News Update December 9, 2021 The LRA is pleased to share positive topline three-year efficacy and safety results reported today by Aurinia...
Good News from Aurinia Pharmaceuticals for Lupus Nephritis News Update September 25, 2018 Congratulations to Aurinia Pharmaceuticals for completing patient enrollment in the AURORA Phase 3 clinical trial ahead of...
Great News for Lupus Nephritis Treatment: Itolizumab Fast-Tracked by FDA News Update December 10, 2019 The Lupus Research Alliance (LRA) is pleased to share that a potential new treatment in development by...